Interleukin-18 protein level is upregulated in adipose tissue of obese mice

Obesity

Volumn 17, Issue 2, 2009, Pages 393-395

  Membrez, Mathieu ^a   Ammon Zufferey, Corinne ^a   Philippe, David ^a   Aprikian, Olivier ^a   Monnard, Irina ^a   MacÉ, Katherine ^a   Darimont, Christian ^a  

^a NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 18; INTERLEUKIN 1BETA CONVERTING ENZYME; MESSENGER RNA;

ADIPOSE TISSUE; ANIMAL; ARTICLE; DISEASE MODEL; GENETICS; LIVER; MALE; METABOLISM; MOUSE; MOUSE MUTANT; OBESITY; UPREGULATION;

ADIPOSE TISSUE; ANIMALS; CASPASE 1; DISEASE MODELS, ANIMAL; INTERLEUKIN-18; LIVER; MALE; MICE; MICE, OBESE; OBESITY; RNA, MESSENGER; UP-REGULATION;

MUS;

EID: 58849094919     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2008.535     Document Type: Article

References (14)

1. Dinarello CA. Interleukin-18 and the pathogenesis of inflammatory diseases. Semin Nephrol 2007;27:98-114.
2. Dinarello CA. Interleukin 1 and interleukin 18 as mediators of inflammation and the aging process. Am J Clin Nutr 2006;83:447S-455S.
3. Rudolphi K, Gerwin N, Verzijl N, van der Kraan P, van den Berg W. Pralnacasan, an inhibitor of interleukin-1Β converting enzyme, reduces joint damage in two murine models of osteoarthritis. Osteoarthritis Cartilage 2003;11:738-46.
4. Bauer C, Loher F, Dauer M et al. The ICE inhibitor pralnacasan prevents DSS-induced colitis in C57BL/6 mice and suppresses IP-10 mRNA but not TNF-a mRNA expression. Dig Dis Sci 2007;52:1642-1652.
5. Wood IS, Wang B, Jenkins JR, Trayhurn P. The pro-inflammatory cytokine IL-18 is expressed in human adipose tissue and strongly upregulated by TNFa in human adipocytes. Biochem Biophys Res Commun2005;337: 422-429.
6. Skurk T, Kolb H, Muller-Scholze S et al. The proatherogenic cytokine interleukin-18 is secreted by human adipocytes. Eur J Endocrinol 2005;152:863-868.
7. Finotto S, Siebler J, Hausding M et al. Severe hepatic injury in interleukin 18 (IL-18) transgenic mice: a key role for IL-18 in regulating hepatocyte apoptosis in vivo. Gut 2004;53:392-400.
8. Bruun JM, Stallknecht B, Helge JW, Richelsen B. Interleukin-18 in plasma and adipose tissue: effects of obesity, insulin resistance, and weight loss. Eur J Endocrinol 2007;157:465-471.
9. Esposito K, Marfella R, Giugliano D. Plasma interleukin-18 concentrations are elevated in type 2 diabetes. Diabetes Care 2004;27:272.
10. Esposito K, Pontillo A, Ciotola M et al. Weight loss reduces interleukin-18 levels in obese women. J Clin Endocrinol Metab 2002;87:3864-3866.
11. Poulain-Godefroy O, Lecoeur C, Pattou F, Fruhbeck G, Froguel P. Inflammation is associated with a decrease of lipogenic factors in omental fat in women. Am J Physiol Regul Integr Comp Physiol 2008;295:R1-R7.
12. Kaneda M, Kashiwamura S, Ueda H et al. Inflammatory liver steatosis caused by IL-12 and IL-18. J Interferon Cytokine Res 2003;23:155-162.
13. Guebre-Xabier M, Yang S, Lin HZ et al. Altered hepatic lymphocyte subpopulations in obesity-related murine fatty livers: potential mechanism for sensitization to liver damage. Hepatology2000;31:633-640.
14. Darimont C, Avanti O, Blancher F et al. Contribution of mesothelial cells in the expression of inflammatory-related factors in omental adipose tissue of obese subjects. Int J Obes 2007;17:17.